9号染色体三体增加干细胞克隆潜能并促进JAK2突变骨髓增殖性肿瘤中的T细胞耗竭
研究探讨9号染色体拷贝数异常对JAK2V617F突变骨髓增殖性肿瘤(MPN)的影响,发现部分MPN患者携带9号染色体部分或完全三体(+9p),具有三个JAK2等位基因及包括CD274在内的邻近基因三个拷贝。+9p患者CD34+细胞克隆形成能力增强,恶性单核细胞PD-L1表面表达升高,细胞毒性T细胞耗竭水平升高。
要点
- +9p MPN患者携带三个JAK2等位基因及CD274等邻近基因三个拷贝。
- +9p患者CD34+细胞因OCT4和NANOG高表达而克隆形成能力增强。
- +9p患者恶性单核细胞PD-L1表面表达升高,细胞毒性T细胞耗竭水平升高。
核心结论
- 研究识别出一个新的MPN患者亚组,其特征为+9p与JAK2V617F协同作用,塑造免疫逃逸特征并增加CD34+细胞的干性。
研究设计与样本
- 研究纳入携带部分或完全9号染色体三体的MPN患者(+9p患者),并与JAK2V617F纯合MPN患者进行比较,分析克隆 hierarchy、CD34+细胞功能及免疫细胞表型。
主要发现
- +9p患者携带三个JAK2等位基因以及包括CD274在内的所有邻近基因三个拷贝。
- 克隆 hierarchy 分析显示JAK2V617F先发生,随后出现+9p。
- +9p患者CD34+细胞克隆形成能力增强,产生更多原始集落,与OCT4和NANOG高表达相关;敲低这些基因导致基因型特异性集落数减少。
- +9p患者恶性单核细胞PD-L1表面表达升高,细胞毒性T细胞耗竭水平升高。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
JAK2V617F is the most recurrent genetic mutation in Philadelphia-negative chronic Myeloproliferative Neoplasms (MPNs). Since the JAK2 locus is located on Chromosome 9, we hypothesized that Chromosome 9 copy number abnormalities may be a disease modifier in JAK2V617F-mutant MPN patients. In this study, we identified a subset of MPN patients with partial or complete Chromosome 9 trisomy (+9p patients), who differ from JAK2V617F-homozygous MPN patients as they carry three JAK2 alleles as well as three copies of all neighboring gene loci, including CD274, encoding immunosuppressive Programmed death-ligand 1 (PD-L1) protein. Investigation of the clonal hierarchy revealed that the JAK2V617F occurs first, followed by +9p. Functionally, CD34+ cells from +9p MPN patients demonstrated increased clonogenicity, generating a greater number of primitive colonies, due to high OCT4 and NANOG expression, with knock-down of these genes leading to a genotype-specific decrease in colony numbers. Moreover, our analysis revealed increased PD-L1 surface expression in malignant monocytes from +9p patients, while analysis of the T cell compartment unveiled elevated levels of exhausted cytotoxic T cells. Overall, here we identify a distinct novel subgroup of MPN patients, who feature a synergistic interplay between +9p and JAK2V617F that shapes immune escape characteristics and increased stemness in CD34+ cells.
引用
- Carretta C, Parenti S, Bertesi M, et al. Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms. Leukemia. 2024. PMID: 39179669. doi:10.1038/s41375-024-02373-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。